Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.

B16-F10 and B16-BL6 are B16 mouse melanoma sublines that preferentially metastasize to the lung following i.v. and s.c. injections, respectively. To study molecular mechanisms underlying the different metastatic behaviors exhibited by the B16 melanoma sublines, we performed differential hybridization of the genes transcribed in these cells and compared their expression levels. We isolated four genes that were highly expressed in B16-F10 cells but not in B16-BL6 cells: TI-225 (polyubiquitin), TI-229 (pyruvate kinase), TI-241 (LRF-1 homologue), and TI-227 (novel gene). Triosephosphate isomerase, 10-formyltetrahydrofolate dehydrogenase, tyrosinase-related protein 2, cytochrome c oxidase, ATP synthetase alpha subunit, RNA helicase, and ribosomal protein (L37, J1, acidic phosphoprotein), however, showed higher expression in B16-BL6 cells than in B16-F10 cells. Among these clones, transfection of TI-241 into the low metastatic clone F1 converted the parental cells from low- into high-metastatic cells. TI-241 may regulate the expression of various genes as a transcription factor in the complex process of metastasis.

[1]  L. Eisenbach,et al.  c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression. , 1994, Oncogene.

[2]  J. Hsu,et al.  Promoter-specific trans-activation and inhibition mediated by JunB. , 1993, Cancer research.

[3]  R Taub,et al.  Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration , 1992, Molecular and cellular biology.

[4]  S. Taniguchi,et al.  Rat elonation factor 1α: sequence of cDNA from a highly metastatic fos-transferred cell line , 1991 .

[5]  T. Ravikumar,et al.  Ubiquitin hybrid protein gene expression during human colon cancer progression. , 1991, Archives of surgery.

[6]  S. Taniguchi,et al.  Rat elongation factor 1 alpha: sequence of cDNA from a highly metastatic fos-transferred cell line. , 1991, Nucleic Acids Research.

[7]  I. Ramshaw,et al.  Isolation of gene associated with high metastatic potential in rat mammary adenocarcinomas. , 1990, Journal of the National Cancer Institute.

[8]  E. Newsholme,et al.  Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. , 1990, The Biochemical journal.

[9]  G. Nicolson,et al.  Metastatic tumor cell interactions with endothelium, basement membrane and tissue. , 1989, Current opinion in cell biology.

[10]  L. Liotta,et al.  Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. , 1989, Biochemistry.

[11]  M. Grigorian,et al.  Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. , 1989, Genes & development.

[12]  R. Kefford,et al.  Differential expression of a novel gene, WDNM1, in nonmetastatic rat mammary adenocarcinoma cells. , 1988, Cancer research.

[13]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[14]  B. V. van Oirschot,et al.  Glycolytic enzyme activities in breast cancer metastases. , 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[15]  I. Fidler,et al.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. , 1980, Cancer research.

[16]  G. Nicolson,et al.  Selection of malignant melanoma variant cell lines for ovary colonization. , 1979, Journal of supramolecular structure.

[17]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.